Therefore, the reduced transcript levels of TRIM28 in IBD patients may contribute to their deficiency in T regulatory cells and the expansion of reactive T lymphocytes, ultimately giving rise to derailed local and systemic immune responses, with consequent autoimmune phenomena in the intestinal tract [36]. Here, TRIM28 is linked to inflammatory bowel disease.